Molecular insights into MYO3A kinase domain variants explain variability in both severity and progression of DFNB30

Amal Souissi1, Dorra Abdelmalek Driss1, Imen Chakchouk2

  • 1Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.